Keyword: Christoph Westphal
Flex Pharma is considering a sale or merger to keep afloat. In the meantime, it has scrapped two midstage trials and is cutting its workforce by 60%.
Details on Westphal's new venture are sketchy, with a corporate filing saying the company is "developing immunotherapy treatments for cancer."
Flex Pharma is on the lookout for a new chief after co-founder Christoph Westphal steps down
The struggling biotech Verastem that has seen its stock nose-dive will look to a future without executive chairman Christoph Westphal and director Henri Termeer.